BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (“CGT”) market, announces the acquisition of privately-held PanTHERA CryoSolutions, Inc., (“PanTHERA”), a developer of novel cryopreservation solutions based on proprietary Ice Recrystallization Inhibitor (“IRI”) technology. The acquisition further strengthens BioLife’s position as the market leader in biopreservation, enhancing its product portfolio of consumable solutions and adds scientific capabilities to the management team.
Read the full article: BioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables Company //
Source: https://www.prnewswire.com/news-releases/biolife-solutions-acquires-panthera-cryosolutions-to-advance-leadership-as-a-pure-play-bioproduction-consumables-company-302421558.html